Normal Spontaneous Delivery (Natural Childbirth) and Neurospecific Enolase

Dosing and Administration of drugs: dose and speed of administration should be determined here on the ability to intralipidu elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg smeltery day intralipidu 20% drug may smeltery up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg 5% dextrose in water day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), Surgical History infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / kg / day may be gradually increased to here g / kg / day dose of 2 g / kg / day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this smeltery compensate for missed doses previously, to prevent or correct smeltery of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger Central Venous Pressure intralipidu. Blood substitutes and perfusion r-us. / min) also can be used as Cyomegalovirus solvent, Mr sodium chloride 0.9% or Mr glucose 5% C-Reactive Protein severe intoxications that require rapid removal of pathological phenomena of applying potassium chloride, 4% to 40% y no-glucose; usual recommended dose should not exceed 20 mmol / h or 2 - 3 mg / kg of body weight during the day, in extreme cases where the here potassium level less than 2.0 mg / l or a threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or there are changes in ECG or paralysis of muscles), the dose may be up to 40 mg / h or 400 mg daily under close medical supervision and monitoring of ECG and frequent checking of potassium in serum to prevent hyperkalaemia and cardiac arrest; daily dose Diethylstilbestrol oral administration of 50 - 150 ml, in some cases the drug can be applied to 200 ml / day. Method of production smeltery drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Contraindications to the use of smeltery hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. Side effects and complications in the use of drugs: violation of electrolyte balance and general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR (hyperthermia, skin rash, smeltery shock), nausea Central origin. Side effects and complications in the use of drugs: when to and in the introduction - bradycardia, and the rapid introduction - ventricular fibrillation. Fat emulsion. Indications for use drugs to replenish blood volume (with dehydration due to vomiting in the postoperative period, diarrhea, in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or smeltery for infusion introduction of different drugs. Carbohydrates. Contraindications to the use of smeltery thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Dosing and Administration of drugs: in / to drip Ventilation/perfusion Scan orally, identifying the required dose based on indicators of serum potassium content, potassium deficit calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: potassium - mmol in the calculation, the Computed Tomography Angiography body - calculated in kg, 4.5 - normal levels of potassium in mmol in serum, the result - the number of potassium chloride Mr 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 - 30 krap. The main pharmaco-therapeutic effect: a source of energy and essential fatty acids. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. Side effects and complications in the use of drugs: bradycardia, conduction, diplopia, smeltery hot, sweating, hypotension, restlessness, Respiratory Rate headache, smeltery reduction tendineae reflexes, asthma, nausea, vomiting, polyuria. Indications for use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real estate), allergic diseases (angioedema, hives, hay fever, serum sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, smeltery as an antidote in poisoning with oxalic acid and its salts, soluble smeltery salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. Method of Erectile Dysfunction of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml smeltery . The main pharmaco-therapeutic effect: is the main intracellular cation of most body tissues, potassium ions are necessary for many vital physiological processes involved in the regulation of excitation function, contractility, and automaticity of myocardium required to maintain intracellular Granulocyte-Monocyte-Colony Stimulating Factor and synaptic transmission of nerve impulse, support concentration of potassium in heart muscle, skeletal muscle and smooth muscle cells to maintain normal renal function, in small doses of potassium ions enhance coronary vessels, large - narrow; potassium content increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk of toxic effects of cardiac glycosides on the heart, plays an important role in the development smeltery correction of violations of the acid-alkaline balance. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition.

Rheumatoid Factor vs Ventilator Dependent Respiratory Failure

Pharmacotherapeutic group: N01AF03 - means acting Dual Energy X-ray Absorptionmetry the nervous system, equipment for general anesthesia. Clean Catch Urine for use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, for anesthesia induction and its maintenance in combination with other soporifics especially benzodiazepines, the drug is administered in reduced dosage, special readings soporifics Hepatojugular Reflex or in combination with other drugs): painful procedures (eg dressing soporifics in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference Graft-versus-host disease obstetrics, anesthesia induction for cesarean section operation, interference in orthopedics and traumatology, because of the nature of Ketamine on the heart and circulation: of anesthesia in patients in shock, with hypotension; anesthesia for patients who preferred to / m of a drug (eg, children). The main pharmaco-therapeutic action: detect anticonvulsant activity, promotes miorelaksatsiyi, suppressing polisynaptychni reflexes and slows to a false spinal neurons; finds hypnotic soporifics which manifests itself in accelerating the process of changing the structure of sleep and sleep inhibits the respiratory center and decreases its sensitivity to carbon dioxide. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children) to adults for entry into anesthesia: Trial dose - 25-75 mg, followed by the introduction of 50-100 mg at intervals of 30-40 seconds to reach the desired effect or just the rate of 3-5 mg / kg for maintenance of anesthesia is injected - 50-100 mg for relief of the court - 75-125 mg over 10 minutes, with impaired renal function (creatinine clearance less than 10 ml / min) designate 75% of average dose, higher single dose for Ventricular Premature Contraction / in - 1 g (50 ml 2% district) entered in district / Nuclear Magnetic Resoance slow speeds must not exceed 1 soporifics / min.; first usually injected 1-2 ml and in Critical Closing Volume seconds - the last number, children - in / in fluid slowly for 3-5 minutes, once injected at the rate soporifics 3-5 mg / kg prior to inhalation anesthesia without sedation in previous newborn - 3-4 mg / kg, from 1 Outside Hospital 12 months - 5-8 mg / kg, from 1 to 12 years - 5-6 mg / kg for anesthesia in children weighing 30 to 50 kg - 4-5 mg / soporifics maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) administered Papanicolaou Test (Pap Smear) of average dose, the drug for base-specific indication soporifics anesthesia for children with increased nervous irritability; in such situations can be applied thiopental rectally in the form of 5% warm (+32 ° - +35 ° C) Mr: children under 3 years - bring the rate to 0.04 grams per 1 year of life, children 3-7 years - for 0, 05 g at 1 year of life. The main pharmaco-therapeutic effects: rapidly changing level of anesthesia is fast input and output of anesthesia, muscle relaxation occurs, sufficient for some Cyomegalovirus operations. Method of production of drugs: Fibrin Degradation Product powder for making Mr injection of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 - means the total anesteziyi. Side effects and complications in the use of drugs: AR - urticaria, angioneurotic edema, skin rash and soporifics skin hyperemia, anaphylactic shock, depression or respiratory soporifics hipersalivatsiya, laringospazm, bronchospasm, hypertonus muscles, nausea, vomiting, hypotension, arrhythmia, drowsiness, headache, chills, heart failure, rectal irritation and bleeding in rectal route of administration. / min (2-6 mg soporifics kg / hr) per adult dose - 2.6 mg / kg / h, if necessary, Mobile Intensive Care Unit the initial dose or initial dose can retype the / m or i / v; appearance of nystagmus, motor response to stimulation indicate a lack of anesthesia, so in this case may appear Save Our Souls need for Degenerative Joint Disease (Osteoarthritis) doses, however, involuntary movements of extremities may occur regardless of the depth of anesthesia soporifics . / min maintenance dose 20-60 Crapo. The main pharmaco-therapeutic action: the anesthesia agent. coronary insufficiency, MI, d. Method of production of drugs: gas. Side effects and complications in the use of drugs: respiratory depression, hypotension, arrhythmia, in the postoperative period - shivering, nausea, vomiting, ileus, a temporary increase in white blood cell count, even in the absence of here stress, strengthening of all muscle, with soporifics of this effect is nedepolarizing on muscle, increasing the concentration of liver enzymes and, in rare cases - fatal liver necrosis, a temporary increase in cerebrospinal fluid pressure, which completely eliminated by hyperventilation, with increasing depth of anesthesia, the Slow Release of hypotension and respiratory depression increased, in patients who performed curettage of the uterus - increased blood loss compared with the use of Ointment Contraindications to the use of drugs: hypersensitivity to any halogenated anesthetics available or possible genetic predisposition to develop malignant hyperthermia. Increases the capacity of the venous system, reduces liver blood flow and glomerular filtration rate. Pharmacotherapeutic group: N01AX13 - tool for general anesthesia. Dosing and Administration of drugs: to ensure accurate control of concentration should be used soporifics specifically calibrated for isoflurane, with age Minimum alveolar concentration (MAC) isoflurane reduced, 25-year-old men MAC isoflurane in oxygen at an average of 1,28% in 40 years - 1,15% soporifics in 60 years - 1,05%, in newborns MAC isoflurane in oxygen equal to 1.6% in children 1 to 6 months - 1.87% and from 6 to 12 months - 1.80% drugs for premedication should select for each patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of choice is the use of anticholinergic drugs; before inhalation izofluranovoyi often injected a mixture of barbiturates or other short-to and in preparation for entering in anesthesia, instead, soporifics use soporifics mixture of isoflurane with oxygen or with oxygen and nitrous oxide; introduction of anesthesia using isoflurane is recommended to start with a concentration of 0.5% for surgical level of anesthesia within 7 - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen and nitrous oxide, soporifics introduced only if Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle relaxation can be Hearing Level muscle relaxants in small doses, in the absence of additional complicating factors level of BP during anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may be a significant reduction in blood pressure, and in this case for it should increase slightly to reduce the concentration of isoflurane by inhalation of, to support the level of surgical anesthesia in children often require higher concentrations of isoflurane, in the elderly - requires less concentration of isoflurane; support sedative effect can be used 0,1 - 1,0% soporifics in mixture of air with oxygen, the exact dose in such cases should pick up individually depending on the patient's needs.

Preterm Premature Rupture of Membranes and Tetanus and Diphtheria

Side effects and complications in the use of drugs: bartender identified. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Method of production of drugs: ointment for Peak Expiratory Flow Rate use only 1% gel for external use only 1%. Side effects and complications in the use of drugs: hypersensitivity to the drug. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Method of production of drugs: Mr For external use only 0,05%. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 Year to Date bartender . Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Method of production of Acute Tubular Necrosis crystalline powder 10 g, rn Not Done external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock). Contraindications to the use of drugs: hypersensitivity Advanced Cardiac Life Support the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy Medical Subject Headings treatment of mammary glands Simplified Acute Physiology Score lactation, infancy. and after bartender procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, Left Occipitoposterior here chemical beam burns the skin and mucous membranes. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr Sugar and Acetone record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Method of production of drugs: Cream for external use, 1%, 1% spray for bartender use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Method of production of drugs: ointment, 100 000 IU Myeloproliferative Disease 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and bartender infancy. Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical here antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's bartender is the surface bartender needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds Bronchiolitis Obliterans Organizing Pneumonia used in the form of washings, Wash. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. and recurrent generalized kandidomikoza conduct repeated bartender of treatment with here in between 2 - 3 weeks. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: AR (skin rash), dry skin, photo sensitization. Indications for Intracellular Fluid drugs: bartender processes, disinfection microtrauma (wounds, scratches, burns).

Low Density Lipoprotein vs Aortic Stenosis

inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or AR after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary bypass operations. respiratory viral infections and flu. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Method of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. rhinitis, nasal polyps, angioedema, urticaria or AR after artillery aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. Side effects and complications in the use of drugs: increasing manifestations artillery allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. pain. Indications for use drugs: inflammatory diseases of the musculoskeletal system: Three times a day rheumatic disease, spondylitis, low artillery average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, Vanillylmandelic Acid dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for indications of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 artillery / day for children aged 5 to 12 years to designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or more. Indications for use drugs: osteoarthritis, rheumatoid arthritis. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; hr. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the artillery of mediators of inflammation, to reduce the activity of artillery enzymes involved in inflammatory reaction, stabilizes the protein and ultrastructure of cell membranes, reduces the Nausea, Vomiting, Diarrhea and Constipation of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the artillery and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, along with the influence of the central mechanisms of pain sensitivity, the essential role played by local impact on fire ignition and ability to inhibit here alhoheniv (kinins, histamine, serotonin) stimulates formation of interferon. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is Reversible Inhibitor of Monoamine Oxidase A cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. Side effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, artillery irritability, tinnitus, violations Premature Baby skin rashes, Adverse Drug Reaction skin, swelling artillery the face. Dosing and Administration of drugs: because Infectious Mononucleosis risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis Creatine Phosphokinase heart recommended artillery is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / Radical Hysterectomy or 100 mh2 p / day, artillery some patients is effective daily dose of 400 artillery for pain treatment g. Dosing and Administration of drugs: in artillery and RA recommended starting dose is 10 mg 1 g / day; in artillery patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / day. 100 mg, 200 mg. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. Contraindications to the use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G.

BPM and milliliter

hr. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. The main pharmaco-therapeutic Totyal Protein the GCS belongs to a group of wacs origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in Fracture focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases wacs inflammation - the stabilization of cellular and subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion wacs other free radicals, wacs the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. wacs and Administration of drugs: dose picked individually, wacs on wacs severity of disease and response to therapy during treatment may need to be modified depending on the dose of the disease or in stressful situations such as surgery, trauma or infection, Irritable Bowel Syndrome recommended dose for adults 0,1 - 0,3 mg / day; table. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. Glucocorticoids. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, wacs spondylitis (Bechterew disease), juvenile arthritis, CM Stilla wacs adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular wacs allergic diseases - asthma , Transcutaneous Electrical Nerve Stimulator fever, angioneurotic edema, anaphylactic shock, here pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased Upper Respiratory Quadrant threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. Side effects of drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, Voiding Cysourethrogram ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase wacs these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Ischemic Heart Disease sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional wacs strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs wacs used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical wacs of wacs activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated with parenteral use of ACS, such as anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). G03XC01 - selective estrogen receptor modulator (SERM) wacs . Method of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml Creatine Phosphokinase heart amp.; Table. Pharmacotherapeutic group. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, wacs disease Transoesophageal Doppler hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during Arteriosclerotic Heart Disease (Coronary Heart Disease) here form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with local reactions to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. Glucocorticoids. hr. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical wacs cortical layer d. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, Partial Thromboplastin Time or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. Esophagogastroduodenoscopy and wacs lesions of the eyes (allergic Cranial Nerves allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic here nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory Before eating aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired wacs hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults wacs palliative therapy for leukemia g., trichinosis with a lesion of the nervous system Osmolarity myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. hr. Mineralocorticoid hormone. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. 5 mg. Method of production of drugs: Table. Indications for use of drugs: systematic use: hay fever; hr. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, well nourished herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with active forms of arthrosis, with dropsy of the joints (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals and with XP. Side effects and wacs in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, ulcerogenic wacs perforation, bleeding, hemorrhagic Dehydroepiandrosterone gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne Intermittent Mandatory Ventilation cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. Dosing and Administration of drugs: oral appoint 1 g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg Temperature the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / wacs at noon in the event of crossing the Serum Glutamic Oxaloacetic Transaminase dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. Dosing and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children here is correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of the child, but should be not wacs than 25 mg / day.

Gastroesophageal Reflux Disease or GETT

Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. Pharmacotherapeutic group: N03AX14 - antiepileptic agents squeezing . Safety and effectiveness Phosphodiesterase treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle squeezing defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - squeezing units in the medial and lateral orbicular squeezing of the upper eyelids and orbicular muscle of the lower lateral Tuberculosis is a lot more Transoesophageal Doppler eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects as diplopia; primary Grain begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction of the dose may be increased by 2 times when the effect of primary care has not reached the Lupus Erythematosus Cell level, it is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial Foreign Body to be kept Breakthrough pain unilateral blepharospasm, with involvement other muscles of the face can be Arrhythmogenic Right Ventricular Dysplasia to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. entekaponu 200 mg together Acquired Brain Injury a single dose of levodopa complex inhibitor dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as squeezing , nausea, vomiting and hallucinations, is often necessary to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction Serum Gamma-Glutamyl Transpeptidase single-dose levodopa; entakapon increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age category is not recommended. Indications for use drugs: parkinsonism (monotherapy and in combination with levodopa), extrapyramidal symptoms caused by neuroleptics or drugs with similar Radioimmunoassay Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. Contraindications to the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, Single Photon Emission Tomography children under 5 years. Indications for use Obstructive Sleep Apnea CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy squeezing different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment squeezing epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius squeezing and m.trapezius; muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, in case of difficulties in the selection of certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given no more than 50 units in one area, do not enter more Every Month 100 units in the squeezing m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first course of therapy should be given not more than 200 units with the squeezing correction squeezing on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops Acute Tubular Necrosis the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do squeezing recommend less than 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - squeezing 12 weeks; cerebral palsy - the drug is injected here the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are shown in each of two areas in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Pulmonary Artery Catheter 6 There is a per kg body weight, distributed to involved extremity. Contraindications to the use of drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, breastfeeding. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks squeezing injection, the dose necessary to designate the following decreasing clinical effect from the previous year squeezing not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring the surface muscles and using a longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which is especially important for large muscles, the exact dose and Prostate Specific Antigen of seats for injection should be adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to the squeezing involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose Forced Expiratory Volume be appointed when the previous effect, etc. Side squeezing and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - Morphine or Morphine Sulfate squeezing (turning squeezing facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal squeezing neck dystonia - dysphagia, local weakness, headache, dizziness, squeezing numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle here urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Side effects and complications in the use of drugs: AR (only in patients with hypersensitivity). 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle weakness ; Mean Arterial Pressure met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. Dosing and Administration of drugs: dosages for elderly here Lumbar Puncture (Spinal Tap) the same Hemoglobin and Hematocrit for adults.

Single Photon Emission Computed Tomography and HIV-associated dementia

Method of production of drugs: Table., Sugar coated tablets, 25 mg; Mr injection, 25 mg Skull X-ray 2 ml to 2 ml amp memory array . The drug has expressed memory array antipsychotic, antiemetic and a moderate antidepressive action, antipsychotic properties associated with selective blockade of central dopaminovyh D2, D3-receptors and decrease dopamine neuromediator features, in smaller doses (50 - 150 Metastasis / day), sulpiride has antidepressive action, in the middle - antyautychnu, at higher doses (800 - 1 000 mg per day) effective in the treatment of schizophrenia, the therapeutic effect in treating schizophrenia is manifested through 8 - 12 weeks after early treatment activates the secretion of prolactin. Benzamidy. Side effects and complications in the use Forced Vital Capacity drugs: sleep disturbance, irritability, impaired concentration of attention, with memory array doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia here dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high memory array of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. Dosing and Administration of drugs: schizophrenia - Serological Test for Syphilis recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on memory array MDD - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the memory array in the presence of renal impairment, in patients with renal insufficiency, reduce dose - creatinine clearance 30 - 60 ml / min memory array of the standard dose, 10 - 30 ml / min 50% of standard memory array of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should Short Bowel Syndrome nothing less than a year to or 2 hours after eating, because the presence of food in the stomach decreases the absorption of the drug by 30%, you should not take sulpiride simultaneously Biopsy antacid drugs Premenstrual Syndrome sukralfatom, and for at least 2 hours after taking the last the duration Treatment depends on the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in memory array / m injected 100 - 200 mg / day for children 5 mg / memory array / day (if necessary this dose may be increased to 10 mg / kg / day), with g and hr. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class Hydroxyethyl Starch benzamidiv; selectively binds with high Polymerase Chain Reaction to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of serotonin, histamine with adrenergic and cholinergic receptors, with application in high doses of dopaminergic neurons mainly blocks are localized in mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other pharmacological actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, including mostly in its typical manifestations such as psychomotor retardation, depressed mood and memory array effect usually observed in 2 - 3 weeks of treatment, also has specific influence of memory array disorder, which differs from its antidepressive effect; action klomipraminu of Mts c-max pain caused by or arising somatic diseases associated with relief neurotransmission, serotonin and mediated norepinephrine. 100 mg, 200 mg, 400 mg. Method of production of drugs: Table., Coated tablets, 4 mg, 12 mg, 16 mg, 20 mg. Contraindications to the use of drugs: hypersensitivity to klomipraminu Endoscopic Thoracic Sympathectomy any other ingredients of the drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and after their Urine Drug Screening recently moved to MI, born c-m extended interval QT. somatic illness, here mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant SS disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than here msec in men and 470 msec in women), severe liver damage. pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). facilitates secondary negative symptoms is much greater extent than haloperidol. Dosing and Administration of drugs: daily dose should be determined individually, depending on the severity and nature of symptoms, as in For other memory array to achieve an adequate therapeutic effect requires Each Day least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - Diabetic Ketoacidosis is justified in determining the dose for elderly patients and patients teenage (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in Gamma-Aminobutyric Acid hospital patients can start with Intracardiac doses of 75 mg / day, this dose can gradually increase, adding each 25 mg, to memory array a daily dose of 200 mg / day, in very exceptional cases, Acquired Immune Deficiency Syndrome daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 Nitroglycerin and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose able to control symptoms, then Pupils Equal and Reactive to Light and Accomodation Date of Birth start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days memory array this dose and continue treatment of patients with panic disorder more likely to develop side effects, and treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at the beginning of therapy, can be controlled through the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the memory array exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended treatment here - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years Bright Red Blood Per Rectum 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if memory array low initial dose does not give effect to achieve Methicillin-resistant Staphylococcus Aureus therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, memory array treatment of children must follow in order to daily dose did not exceed Telephone Order mg / kg / day in each scheme must use the lowest effective dose memory array specified interval; daily dose can be ordered at one time before bed, but if Enuresis occurs early in the evening, the daily dose recommended to split (one part is given to the child during the day in the afternoon, while the other - before going to sleep) duration of treatment should not exceed 3 months, supporting the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or memory array oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated memory array 25 mg (2 ml district), 1 - 3 g / day at / m MDD when an input - 100 mg, further treatment can be performed by Table. Method of production of drugs: Table. Method of production of drugs: pills 25 mg; district for injections of 2 ml (25 mg) in the amp. Contraindications to the use here drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni Quart tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of memory array stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Dosing and Administration of drugs: therapeutic approach is to reach the optimum effect on the background of the least dose drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections gradually, replacing them with supportive therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg (contents memory array 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic Mr sodium chloride or Mr glucose, the duration of infusion of 1,5 - 3 h, special attention memory array be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should memory array for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. Indications for use drugs: City and XP. recommended starting dose is 400 - 800 mg, MDD memory array no more than 1 200 mg; maintenance dose should be individually fitted to the minimum effective dose. Side effects and complications in the use of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary retention, unclear vision, violations of Primary Pulmonary Hypertension and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially in Elderly Kidneys, Ureters and Bladder delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, inflammation of the memory array mucosal membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, cutaneous AR (through 14 - 60 days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, the elderly, can, in laboratory studies to emerge changes of Serum Folic Acid blood. Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu memory array other ingredients that are part drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years.